Found 102 matching trials
Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab PHASE2 This is a multi-center, single arm study to evaluate the efficacy and safet...
Show More Location
No.2 People's Hospital of Fuyang city
Learn More & Join Trial
Single-arm, Single-center, Exploratory Phase II Clinical Study of Envafolimab Combined With Chemoradiotherapy in the Treatment of Locally Advanced pMMR/MSS Rectal Cancer PHASE2 Preoperative radiotherapy combined with 5-fluorouracil/capecitabine is curr...
Show More Learn More & Join Trial
A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment PHASE2 This study is a multicenter, prospective, randomized controlled Phase II cl...
Show More Location
Beijing Cancer Hospital, 52 Fucheng Road
Learn More & Join Trial
Cetuximab Ξ² Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors PHASE2 This study is a single-arm, multi-center, prospective clinical study aimed ...
Show More Location
The Second Affiliated Hospital of Soochow University
Learn More & Join Trial
KN035 in Combination With Trastuzumab and Docetaxel in HER2-positive Breast Cancer PHASE2 This is an open-label, single arm phase II trial to evaluate the efficacy, ...
Show More Location
Multiple Locations
Learn More & Join Trial
Envafolimab Plus Chemoradiotherapy for Locally Advanced NPC, a Prospective, Single Armed Phase II Trial. PHASE2 Patients diagnosed with locally advanced nasopharyngeal carcinoma will be r...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma PHASE2 Introduction:
This document explains a clinical research study conducted a...
Show More Location
Multiple Locations
Learn More & Join Trial
JSKN033 in Patients With Advanced or Metastatic Solid Malignant Tumors PHASE1 This study is an open-label, multicenter, first-in-human, Phase I/II (dose ...
Show More Location
Scientia Clinical Research
Learn More & Join Trial
Clinical Experience and Real-world Safety and Effectiveness of Envafolimab: Patient Access Program N/A Envafolimab is a novel PD-L1 inhibitor administered via subcutaneous (SC) i...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors PHASE1 This is an open-label, multi-center study of Phase Ib/II study to assess th...
Show More Location
The First Affiliated Hospital of Bengbu Medical College
Learn More & Join Trial